Predictors of success in the conversion of new—onset atrial fibrillation using oral propafenone

Ergene U., ERGENE A. O., Cete Y., Flower J., Nazli C., Okaty C.

European Journal of Emergency Medicine, vol.5, no.4, pp.425-428, 1998 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 5 Issue: 4
  • Publication Date: 1998
  • Doi Number: 10.1097/00063110-199812000-00008
  • Journal Name: European Journal of Emergency Medicine
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.425-428
  • Keywords: Cardioversion, New-onset atrial fibrillation, Propafenone
  • Dokuz Eylül University Affiliated: Yes


We have investigated the relationship of clinical variables to successful cardioversion of atrial fibrillation (AF) to sinus rhythm using an oral loading dose of propafenone. Fifty consecutive patients with recent onset (< 72 hours) atrial fibrillation of various aetiologies were included in the study cohort. All patients were given the study medication while in the emergency department and then monitored for 8 hours. All patients converting to sinus rhythm (39 out of 50, 78%) were discharged and re-evaluated at 24 hours and 30 days. We investigated the effect of clinical factors such as age, sex, presence of hypertension (HT), chronic obstructive lung disease (COPD), diabetes mellitus (DM), mitral stenosis (MS), congestive heart failure (CHF), coronary artery disease (CAD) and the duration of atrial fibrillation on conversion to sinus rhythm. Of these factors, univariate and multivariate analysis showed that only the duration of atrial fibrillation was a significant predictor of conversion (p = 0.002). Our results suggest that most patients with new-onset AF can be converted successfully to sinus rhythm with a low incidence of adverse reactions using oral propafenone in the emergency department. © 1998 Lippincott Williams and Wilkins.